Skip to content
10-K

Annual Report

Celator Pharmaceuticals Inc

0001144204-16-089052

← back to feed
Filed
Mar 21, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 18, 2016 36.39M sh
Capex FY 2015 · Dec 31, 2015 $55.36K
Capex FY 2015 · Dec 31, 2014 $64.87K
Long Term Debt FY 2015 · Dec 31, 2015 $9.5M
Long Term Debt FY 2015 · Dec 31, 2014 $9.84M
Short Term Debt FY 2015 · Dec 31, 2015 $5.38M
Short Term Debt FY 2015 · Dec 31, 2014 $284.96K
Cash And Equivalents FY 2015 · Dec 31, 2015 $23.25M
Cash And Equivalents FY 2015 · Dec 31, 2014 $32.41M
Cash And Equivalents FY 2015 · Dec 31, 2013 $23.59M
Stockholders Equity FY 2015 · Dec 31, 2015 $6.53M
Stockholders Equity FY 2015 · Dec 31, 2014 $21.91M
Stockholders Equity FY 2015 · Dec 31, 2013 $23.46M
Current Liabilities FY 2015 · Dec 31, 2015 $8.58M
Current Liabilities FY 2015 · Dec 31, 2014 $3.29M
Total Liabilities FY 2015 · Dec 31, 2015 $19.1M
Total Liabilities FY 2015 · Dec 31, 2014 $13.21M
Current Assets FY 2015 · Dec 31, 2015 $24.31M
Current Assets FY 2015 · Dec 31, 2014 $33.57M
Total Assets FY 2015 · Dec 31, 2015 $25.64M
Total Assets FY 2015 · Dec 31, 2014 $35.12M
Sga Expense FY 2015 · Dec 31, 2015 $7.67M
Sga Expense FY 2015 · Dec 31, 2014 $7.29M
Rd Expense FY 2015 · Dec 31, 2015 $11.77M
Rd Expense FY 2015 · Dec 31, 2014 $11.89M
Net Income FY 2015 · Dec 31, 2015 −$19.32M
Net Income FY 2015 · Dec 31, 2014 −$16.9M
Operating Income FY 2015 · Dec 31, 2015 −$18.2M
Operating Income FY 2015 · Dec 31, 2014 −$17.91M